Inhibition of Tumor Development by Class-3 Semaphorins
Author Information
Author(s): Kigel Boaz, Varshavsky Asya, Kessler Ofra, Neufeld Gera
Primary Institution: Cancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
Hypothesis
Do additional class-3 semaphorins possess anti-angiogenic and anti-tumorigenic properties?
Conclusion
Class-3 semaphorins can inhibit tumor development and angiogenesis, but their effectiveness is correlated with the expression of specific receptors on tumor cells.
Supporting Evidence
- Sema3A, Sema3D, Sema3E, and Sema3G were shown to have anti-tumorigenic properties.
- Expression of semaphorins correlated with reduced tumor-associated blood vessel density.
- Different semaphorins had varying effects on tumor growth depending on the tumor cell type.
Takeaway
Certain proteins called semaphorins can help stop tumors from growing by blocking blood vessel formation, but they work best when the tumor cells have the right receptors for them.
Methodology
The study involved expressing recombinant semaphorins in various tumor cell lines and assessing their effects on tumor growth and angiogenesis in vivo.
Potential Biases
Potential bias due to the lack of specific antibodies for all semaphorin receptors.
Limitations
The study did not systematically test all potential modulating influences on semaphorin signaling.
Participant Demographics
The study used various human breast cancer cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website